Related Experiment Video

Updated: Jul 6, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Experiences of parents of young people with diabetes using insulin pump therapy

Valerie Wilson1

  • 1Canterbury Christ Church University.

Paediatric Nursing
|March 21, 2008
PubMed

Insights

Insulin pump therapy for children with type 1 diabetes offers improved quality of life and flexibility. Parental experiences highlight challenges in accessing information and treatment, despite significant benefits.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Health Services Research

Background:

  • National guidance for insulin pump therapy in adults with type 1 diabetes is applicable to children.
  • Access to insulin pump therapy for pediatric patients is often limited by healthcare professional availability rather than clinical need.

Purpose of the Study:

  • To investigate the experiences of parents whose children use insulin pump therapy for type 1 diabetes.

Main Methods:

  • A survey was conducted with parents of 44 children and young people (aged 1-16 years) using insulin pumps.
  • Data were collected via email or postal self-completion questionnaires from participants identified through support groups.

Main Results:

  • Analysis revealed issues with accessing pump information from NHS sources and high initial refusal rates from diabetes teams.
  • Parents reported challenges with distance to pump-trained teams, but also highlighted benefits, choice, and their involvement in care plans.
  • Key themes included reasons for starting therapy, information needs, and assistance required post-initiation.

Conclusions:

  • Insulin pump therapy provides flexibility, choice, and an improved quality of life for children with type 1 diabetes and their families.
  • Despite study limitations in generalizability due to small scale, findings suggest significant advantages of pump therapy.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...